• Wnt and BMP Gradients Pattern Anterior Neuroectoderm in Hemi

  2026-06-28

  This study provides new mechanistic insights into how Wnt and BMP signaling pathways pattern the anterior neuroectoderm (ANE) in the indirect-developing hemichordate Ptychodera flava. The findings reveal conserved and unique pathway roles, with implications for evolutionary developmental biology and experimental design in Wnt pathway research.

• USP18-Mediated Autophagic Degradation Regulates GSDMD Pyropt

  2026-06-27

  Wang et al. reveal that USP18 suppresses pyroptosis by promoting selective autophagic degradation of Gasdermin D (GSDMD) through K168 ubiquitination. These findings provide mechanistic insight into immune regulation and offer new avenues for targeting inflammatory diseases.

• Moxidectin: Macrocyclic Lactone Anthelmintic for Antifungal

  2026-06-26

  Moxidectin, long valued for robust parasitic worm control, is now revolutionizing antifungal research by synergizing with polyenes to combat drug-resistant Candida albicans. Discover how APExBIO’s high-purity moxidectin streamlines experimental workflows, enhances reproducibility, and opens new translational frontiers for clinical and preclinical assays.

• Acetylation-Regulated Spliceosome Drives PARP Inhibitor Sens

  2026-06-26

  This study reveals that acetylation-dependent regulation of the core spliceosome protein SmD2 influences DNA repair and alternative splicing in hepatocellular carcinoma (HCC). Targeting SmD2 acetylation increases sensitivity to PARP inhibitors, suggesting new combinatorial strategies for treating BRCA-proficient HCC.

• Nonconventional Agonist-Antagonist Interplay at the GLP-1 Re

  2026-06-25

  This study redefines the selectivity of glucagon and GLP-1 receptor ligands, revealing that glucagon can function as a nonconventional agonist at the GLP-1 receptor. High-throughput FRET assays demonstrate complex cross-reactivity between agonists and antagonists, impacting the interpretation of metabolic and diabetes research.

• SW033291: 15-PGDH Inhibitor Workflows for Muscle & Stem Cell

  2026-06-25

  SW033291 empowers precision modulation of prostaglandin E2 for advanced tissue regeneration research and hematopoietic stem cell expansion. Its application uniquely counteracts muscle repair deficits during GLP-1 RA–induced weight loss, opening new translational avenues for musculoskeletal and hematopoietic studies.

• AAL-993: Precision VEGF Receptor Inhibitor for Tumor Models

  2026-06-24

  AAL-993 provides exceptional selectivity and potency as a VEGF receptor inhibitor, enabling robust, reproducible angiogenesis studies in tumor models. Its well-characterized performance profile and protocol-friendly formulation make it a standout anti-angiogenic compound for both in vitro and in vivo research.

• gamma-Glu-Cys (γ-Glu-Cys): Technical Guide for Lab Use

  2026-06-23

  gamma-Glu-Cys (γ-Glu-Cys) is an essential substrate for L-glutathione biosynthesis and a key intermediate in glutathione metabolism research. It is specifically suited for workflows involving glutathione synthetase assays, thiol-reactive peptide synthesis, and plant stress adaptation studies. This product is not intended for diagnostic, clinical, or therapeutic applications.

• Protein A/G Magnetic Co-IP/IP Kit: Innovations in Mitophagy

  2026-06-23

  Discover how the Protein A/G Magnetic Co-IP/IP Kit advances co-immunoprecipitation of protein complexes and mitophagy analysis in neurodegenerative disease research. This article delivers a unique, scientifically rigorous perspective on experimental design and translational impact.

• α2-Adrenergic Receptor Agonists for Immune Modulation in OS

  2026-06-22

  This study pioneers the use of α2-adrenergic receptor agonists, delivered via thermo-sensitive hydrogel, to reduce immune rejection and tumor recurrence in post-surgical osteosarcoma. The findings reveal a unique immune-mediated mechanism that enhances CD8+ T cell activation, offering new directions for immunomodulatory research in oncology.

• EZ Cap™ EPO mRNA: Precision Tools for Neurorepair & Erythrop

  2026-06-22

  EZ Cap™ EPO mRNA (ψUTP) sets a new benchmark for translational research, delivering superior mRNA stability, translatability, and immune stealth for both erythropoiesis and neurorepair applications. Its advanced Cap 1 structure and pseudouridine modifications directly empower high-yield protein expression and targeted therapeutic workflows.

• Ertapenem Sodium Salt: Next-Gen Strategies for Resistance Re

  2026-06-21

  This thought-leadership article explores the mechanistic underpinnings and translational research strategies enabled by Ertapenem (sodium salt) in the evolving landscape of antimicrobial resistance. Drawing upon recent epidemiological findings from Guangdong, China, and integrating advanced workflow perspectives, it offers actionable insights for researchers confronting multidrug-resistant pathogens. The discussion bridges molecular pharmacology, experimental optimization, and the systemic implications of resistance gene transmission, ultimately charting a forward-looking vision for translational microbiology.

• PPP2R2A Loss Sensitizes Ovarian Cancer to CHK1 Inhibition

  2026-06-20

  This study demonstrates that low PPP2R2A expression increases replication stress and makes high-grade serous ovarian cancer (HGSOC) cells more sensitive to CHK1 inhibition, even in settings of PARP inhibitor resistance. The findings identify PPP2R2A as both a predictive biomarker and a potential therapeutic target to improve treatment stratification in HGSOC.

• Advances in In Vitro Drug Response Evaluation for Cancer Res

  2026-06-19

  Schwartz's dissertation introduces a refined conceptual and methodological framework for distinguishing between growth inhibition and cell death in in vitro anti-cancer drug assessment. These insights offer greater resolution for interpreting compound efficacy, with practical implications for evaluating agents like polyether ionophore antibiotics in hepatocellular carcinoma research.

• Norovirus Hijacks NINJ1 for Selective NS1 Protein Secretion

  2026-06-19

  This study uncovers how murine norovirus (MNoV) exploits the cell death protein NINJ1 to enable selective secretion of its NS1 protein, revealing a previously unrecognized viral strategy for modulating host responses. The findings advance understanding of unconventional protein secretion and its interplay with regulated cell death, with implications for antiviral and cell biology research.

449 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page